Computational Biology:  Application and Advocacy
<p>
Barbara Bryant, Millennuim Pharmaceuticals and International Society for Computational Biology 
<p> 
This will be two talks in one time slot.  I will present results from a
Millennium Pharmaceuticals project, gene expression profiling and
correlation with outcome in clinical trials of the proteasome inhibitor
bortezomib.  I will also talk about science policy advocacy with the
help of the Federation of American Societies for Experimental Biology
and the International Society for Computational Biology.
<p> 
<a href="http://bcb.cs.tufts.edu/bcb-seminar.html"> back to main page </a>